Evidence map›Paper›PMID 40686092›Full record

ArticleJournal of cosmetic dermatology2025

Dermatologically Tested Apple-Derived Extracellular Vesicles: Safety, Anti-Aging, and Soothing Benefits for Skin Health.

Lucia Sileo, Maria Pia Cavaleri, Luca Lovatti, Giuseppe Pezzotti, Letizia Ferroni, Barbara Zavan

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Apple-Derived Vesicles Orchestrate Bone Regeneration:International journal of molecular sciences · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucia SileoMedical Science Department, University of Ferrara, Ferrara, Italy.
Maria Pia CavaleriMedical Science Department, University of Ferrara, Ferrara, Italy.
Luca LovattiMedical Science Department, University of Ferrara, Ferrara, Italy.
Giuseppe PezzottiBiomedical Research Center, Kansai Medical University, Osaka, Japan.
Letizia FerroniMaria Cecilia Hospital, GVM Care and Research, Ravenna, Italy.
Barbara ZavanMedical Science Department, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-4779-4456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) derived from plant sources, particularly apple-derived vesicles (ADVs), have gained interest for their biocompatibility and bioactive properties in cosmetic, dermatological, and regenerative medicine applications. This study aimed to evaluate the safety and efficacy of a 2% ADV-based formulation, assessing its potential for topical use through a series of standardized in vitro tests. MATERIALS AND

methodsThe ADV-based formulation was subjected to genotoxicity (Ames test), corneal toxicity, skin irritation, corrosion, and sensitization assays, following OECD guidelines. Additionally, its anti-inflammatory and anti-aging effects were assessed through skin redness reduction and wrinkle parameter analysis over 60 days.

resultsADVs exhibited no genotoxic, cytotoxic, corrosive, or sensitizing effects, confirming their safety profile. The formulation significantly reduced skin redness (p < 0.05) and improved wrinkle length, volume, and roughness over time.

conclusionThese findings establish ADVs as safe and effective bioactive ingredients, supporting their potential integration into cosmetic and regenerative applications for skin health and anti-aging treatments.

Indexed as

Extracellular VesiclesMalusSkin AgingAnimalsFruitHumansSkinbiological targetscomputational methodsnanoparticlesnatural productspharmaceutical formulationspharmaceutical processespharmacodynamicspharmacogenomics and pharmacogeneticspharmacokinetics

Identifiers

PMID40686092
PMCPMC12278024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.